nach oben

Sports Medicine

Erschienen in:

01.03.2003 | Leading Article

Use of Nonsteroidal Anti-Inflammatory Drugs Following Exercise-Induced Muscle Injury

verfasst von: Angela Baldwin Lanier

Erschienen in: Sports Medicine | Ausgabe 3/2003

Einloggen, um Zugang zu erhalten

Abstract

The objective of this article is to examine the use of NSAIDs for attenuating exercise-induced muscle injuries (EIMI), with an emphasis on their safety and usefulness for improving muscle function and reducing soreness. NSAIDs are some of the most widely consumed medications in the world, and NSAID use as therapy for EIMI has increased dramatically over the last 20 years. However, there is a lack of agreement concerning NSAID effectiveness for this purpose. The lack of consensus about the efficacy of NSAID use in relation to EIMI has spawned a recent interest in sports medicine research regarding NSAIDs.

The application of a variety of methods used to induce, assess and quantify muscle injury has contributed to the inconsistency among the findings regarding the efficacy of NSAIDs for EIMI. Therefore, future studies should focus on the evaluation of muscle injury and function, with the use of better functional measurement tools and more uniformity in the assessment tools used. However, from review of the current literature, it is concluded that NSAID use for brief periods of time is beneficial for short-term recovery of muscle function and is an important laboratory tool for the study of EIMI.

Wallace J. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000–16PubMedCrossRef

Robinson DR. Prostaglandins and the mechanism of action of anti-inflammatory drugs. Am J Med 1983 Oct 31; 75: 26–31PubMedCrossRef

Vane J. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232–5

Williams TJ, Peck MJ. Role of prostaglandin-mediated vasodilation in inflammation. Nature 1977; 270: 530–2PubMedCrossRef

Vane JR, Botting RM. Mechanism of anti-inflammatory drugs. Scand J Rheumatol 1996; 25Suppl. 102: 9–21CrossRef

Sirois J, Richards JS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulose cells of rat preovulatory follicles. J Biol Chem 1992; 267: 6382–8PubMed

Griffin M. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104(Suppl. 3A): 23S–9SPubMedCrossRef

Hernandez-Diaz S, Garcia-Rodriguez G. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med 2001; 110(Suppl. 3A): 20S–7SPubMedCrossRef

Koch M, Dezi A, Ferrario F, et al. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Arch Intern Med 1996; 156: 2321–32PubMedCrossRef

10.

Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340(24): 1888–99PubMedCrossRef

11.

Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 1994; 331: 1675–8PubMedCrossRef

12.

Farquhar WB, Morgan AL, Azmbraski EJ, et al. Effects of acetaminophen and ibuprofen on renal function in the stressed kidney. J Appl Physiol 1999; 86(2): 598–604PubMed

13.

Henry D, Page J, Whyte I, et al. Consumption of nonsteroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects: results of a case-controlled study. Br J Clin Pharmacol 1997; 44: 85–90PubMedCrossRef

14.

Sandler D, Burr F, Weinberg C. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991; 155: 165–72

15.

Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med 2000; 160: 777–84PubMedCrossRef

16.

Greene GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 2001; 3(5): 50–60CrossRef

17.

Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1993; 90: 11693–7PubMedCrossRef

18.

Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104(5): 413–21PubMedCrossRef

19.

Slatis P, Ruusinen A. Orthopedic diseases and trauma in Finland: trends in consumption of health services 1970–1985. Acta Orthop Scand Suppl 1991; 241: 13–6PubMed

20.

Asmussen E. Observations on experimental muscular soreness. Acta Rheumatol Scand 1956; 2: 109–16PubMed

21.

Davies CT, White MJ. Muscle weakness following eccentric work in man. Pflugers Arch 1981; 392: 168–71PubMedCrossRef

22.

Armstrong RB, Ogilvie RW, Schwane JA. Eccentric exercise-induced injury to rat skeletal muscle. J Appl Physiol 1983; 54: 80–93PubMed

23.

Lieber RL, Friden J. Morphologic and mechanical basis of delayed-onset muscle soreness. J Am Acad Orthop Surg 2002; 10: 67–73PubMed

24.

Dedrick ME, Clarkson PM. The effects of eccentric exercise on motor performance in young and older women. Eur J Appl Physiol 1990; 60: 183–6CrossRef

25.

Manfredi TG, Fielding RA, O’Reilly KP, et al. Plasma creatine kinase activity and exercise-induced muscle damage in older men. Med Sci Sports Exercise 1991; 23: 1028–934

26.

Roth SM, Martel GF, Ivey FM, et al. High-volume, heavy-resistance strength training and muscle damage in young and older women. J Appl Physiol 2000; 88(3): 1112–8PubMed

27.

Roth SM, Martel GF, Ivey FM, et al. Ultrastructural muscle damage in young vs older men after high-volume, heavy-resistance strength training. J Appl Physiol 1999; 86(6): 1833–40PubMed

28.

Morgan DL, Allen DG. Early events in stretch-induced muscle damage. J Appl Physiol 1999; 87(6): 2007–15PubMed

29.

Warren GL, Ingalls CP, Lowe DA, et al. What mechanisms contribute to the strength loss that occurs during and in the recovery from skeletal muscle injury. J Orthop Sports Phys Ther 2002; 32: 58–64PubMed

30.

Leiber RL, Thornell LE, Friden J. Muscle cytoskeletal disruption occurs within the first 15 minutes of cyclic eccentric contraction. J Appl Physiol 1996; 80: 278–84CrossRef

31.

Patel TJ, Cuizon D, Mathieu-Costello O, et al. Increased oxidative capacity does not protect skeletal muscle fibers from eccentric contraction-induced injury. Am J Physiol 1998; 274 (5 Pt 2): R1300–8PubMed

32.

Leiber RL, Friden J. Muscle damage is not a function of muscle force but active muscle strain. J Appl Physiol 1993; 74: 520–6

33.

Leiber RL, Friden J. Selective damage of fast glycolytic muscle fibres with eccentric contraction of the rabbit tibialis anterior. Acta Physiol Scand 1998; 133: 587–8CrossRef

34.

Gibala MJ, MacDougal JD, Tarnopolsky MA, et al. Changes in human skeletal muscle ultrastructure and force production after acute resistance exercise. J Appl Physiol 1995; 78: 702–8PubMed

35.

Lieber RL, Woodburn TM, Friden J. Muscle damage induced by eccentric contractions of 25% strain. J Appl Physiol 1991; 70: 2498–507PubMed

36.

O’Reilly KP, Warhol MJ, Fielding RA, et al. Eccentric exercise-induced muscle damage impairs muscle glycogen repletion. J Appl Physiol 1987; 63: 252–6PubMed

37.

McBride TA, Stockert BW, Gorin FA, et al. Stretch-activated ion channels contribute to membrane depolarization after eccentric contractions. J Appl Physiol 2000; 88: 91–101PubMed

38.

Grounds MD. Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age, and sex of host mice. J Pathol 1987; 153: 71–82PubMedCrossRef

39.

MacIntyre DL, Reid WD, McKenzie DC. Delayed muscle soreness: the inflammatory response to muscle injury and its clinical implications. Sports Med 1995; 20: 24–40PubMedCrossRef

40.

Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 1995; 27: 1022–32PubMedCrossRef

41.

Friden J, Leiber RL. Segmental muscle fiber lesions after repetitive eccentric contractions. Cell Tissue Res 1998; 293: 165–71PubMedCrossRef

42.

Malmsten CL. Prostaglandins, thromboxanes, and leukotrienes in inflammation. Am J Med 1986; 80: 11–7PubMedCrossRef

43.

Hurley JV. Acute inflammation. New York: Churchill Livingstone, 1983

44.

Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nature 1972; 240: 200–3CrossRef

45.

Rodemann HP, Waxman K, Goldberg L. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease. J Biol Chem 1982; 257: 8716–23PubMed

46.

Ebbeling CB, Clarkson PM. Exercise induced muscle damage and adaptation. Sports Med 1989; 7: 207–34PubMedCrossRef

47.

Peeze Binkhorst FM, Slaaf DW, Kuipers H, et al. Exercise-induced swelling of rat soleus muscle: its relationship with intramuscular pressure. J Appl Physiol 1990; 69: 67–73PubMed

48.

Warren GL, Lowe DA, Hayes DA, et al. Excitation failure in mouse soleus muscle injured by eccentric contractions. J Physiol 1993; 468: 487–99PubMed

49.

Balnave CD, Davey DF, Allen DG. Distribution of sarcomere length and intracellular calcium in mouse skeletal muscle following stretch-induced injury. J Physiol 1997; 502: 649–59PubMedCrossRef

50.

Ingalls CP, Warren GL, Williams JH, et al. E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. J Appl Physiol 1998; 85: 58–67PubMed

51.

Warren GL, Ingalls CP, Shah SJ, et al. Uncoupling of in vivo torque production from EMG in mouse muscle injured by eccentric contractions. J Physiol 1999; 515: 609–19PubMedCrossRef

52.

Warren GL, Lowe DA, Armstrong RB. Measurement tools used in the study of eccentric contraction-induced injury. Sports Med 1999; 27(1): 43–59PubMedCrossRef

53.

Baldwin AC, Stevenson SW, Dudley GA. Non-steroidal anti-inflammatory therapy after eccentric exercise in healthy older individuals. J Gerontol A Biol Sci Med Sci 2001; 56(8): M510–3PubMedCrossRef

54.

Barlas P, Craig JA, Robinson J, et al. Managing delayed-onset muscle soreness: lack of effect of selected oral systemic analgesics. Arch Phys Med Rehabil 2000; 81: 966–72PubMedCrossRef

55.

Bourgeois J, MacDougall D, MacDonald J, et al. Naproxen does not alter indices of muscle damage in resistance-exercise trained men. Med Sci Sports Exerc 1999; 31: 4–9PubMedCrossRef

56.

Donnelly AE, McCormick K, Maughan RJ, et al. Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage. Br J Sports Med 1988; 22: 325–8CrossRef

57.

Donnelly AE, Maughan RJ, Whiting PH. Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage. Br J Sports Med 1990; 24: 191–5PubMedCrossRef

58.

Dudley GA, Czerkawski J, Meinrod A, et al. Efficacy of naproxen sodium for exercise-induced dysfunction, muscle injury and soreness. Clin J Sport Med 1997; 23: 1–6CrossRef

59.

Francis KT, Hoobler T. Effects of aspirin on delayed muscle soreness. J Sports Med 1987; 27: 333–7

60.

Hasson SM, Daniels JC, Divine JG, et al. Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation. Med Sci Sports Exerc 1993; 25: 9–17PubMedCrossRef

61.

Kuipers H, Keizer HA, Verstappen FTJ, et al. Influence of a prostaglandin-inhibiting drug on muscle soreness after eccentric work. Int J Sports Med 1985; 6: 336–9PubMedCrossRef

62.

Lecomte JM, Lacroix VJ, Montgomery DL. A randomized controlled trial of the effect of naproxen on delayed onset muscle soreness and muscle strength. Clin J Sports Med 1998; 8(2): 82–7CrossRef

63.

Lapointe BM, Fremont P, Cote CH. Adaptation to lengthening contractions is independent of voluntary muscle recruitment but relies on inflammation. Am J Physiol Regul Integr Comp Physiol 2002; 282(1): R323–9PubMed

64.

Mishra DK, Friden J, Schmitz MC, et al. Anti-inflammatory medication after muscle injury: a treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg 1995; 77(10): 1510–9PubMed

65.

O’Grady M, Hackney AC, Schneider K, et al. Diclofenac sodium (Voltaren) reduced exercise-induced injury in human skeletal muscle. Clin Sci 1999; 32(7): 1191–6

66.

Pizza FX, Cavender D, Stockard A, et al. Anti-inflammatory doses of ibuprofen: effect on neutrophils and exercise-induced muscle injury. Int J Sports Med 1999; 20(2): 98–102PubMed

67.

Sayers SP, Knight CA, Clarkson PM, et al. Effect of ketoprofen on muscle function and sEMG activity after eccentric exercise. Med Sci Sports Exerc 2000; 33(5): 702–10

68.

Semark A, Noakes TD, St Clair A, et al. The effect of a prophylactic dose of flurbiprofen on muscle soreness and sprinting performance in trained subjects. J Sports Sci 1999; 17(3): 197–203PubMedCrossRef

69.

Fiatarone MA, Evans WJ. The etiology and reversibility of muscle dysfunction in the aged. J Gerontol 1993; 48: 77–83PubMedCrossRef

70.

Miles MP, Clarkson PM. Exercise-induced muscle pain, soreness, and cramps. J Sports Med Phys Fitness 1994; 34: 203–16PubMed

71.

Newham DJ, McPhail G, Mills KR, et al. Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci 1983; 61: 109–22PubMedCrossRef

72.

Ploutz-Snyder LL, Tesch PA, Dudley GA. Increased vulnerability to eccentric exercise-induced dysfunction and muscle injury after concentric training. Arch Phys Med Rehabil 1998; 79: 58–61PubMedCrossRef

73.

Nosaka K, Sakamoto K, Newton M, et al. How long does the protective effect on eccentric exercise-induced muscle damage last? Med Sci Sports Exerc 2000; 33(9): 1490–5

74.

Clarkson PM, Ebbeling C. Investigations of serum creatine kinase variability after muscle-damaging exercise. Clin Sci 1988; 75: 257–61PubMed

75.

Hortobagyi T, Denahan T. Variability in creatine kinase: methodological, exercise, and clinically related factors. Int J Sports Med 1989; 10: 69–80PubMedCrossRef

76.

Meltzer HY. Factors affecting serum creatine phosphokinase levels in the general population: the role of race, activity, and age. Clin Chim Acta 1971; 33: 165–72PubMedCrossRef

77.

Jones DA, Newham DJ, Round JM, et al. Experimental human muscle damage: morphological changes in relation to other indices of damage. J Appl Physiol 1986; 375: 435–48

78.

Evans GF, Haller RG, Wyrick PS, et al. Submaximal delayed-onset muscle soreness: correlations between MR imaging findings and clinical measures. Radiology 1998; 208(3): 815–20PubMed

79.

Fleckenstein JL, Canby RC, Parkey RW, et al. Acute effects of exercise on MR imaging of skeletal muscle in normal volunteers. Am J Roentgenol 1988; 151(2): 231–7

80.

Fleckenstein JL, Peshock RM, Lewis SL, et al. Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies. Muscle Nerve 1989; 12: 849–55PubMedCrossRef

81.

Fleckenstein JL, Weatherall PT, Parkey RW, et al. Sports-related muscle injuries: evaluation with MR imaging. Radiology 1989; 172: 793–8PubMed

82.

LeBlanc AD, Jaweed M, Evans H. Evaluation of muscle injury using magnetic resonance imaging. Clin J Sports Med 1993; 3: 26–30CrossRef

83.

Speer KP, Lohnes J, Garrett WE. Radiographic imaging of muscle strain injury. Am J Sports Med 1993; 21: 89–96PubMedCrossRef

84.

Shellock FG, Fukunaga T, Mink JH, et al. Acute effects of exercise on MR imaging of skeletal muscle: concentric vs eccentric actions. Am J Roentgenol 1991; 156(4): 765–8

85.

Takahashi H, Kuno S, Miyamoto T, et al. Changes in magnetic resonance images in human skeletal muscle after eccentric exercise. Eur J Appl Physiol 1994; 69: 408–13CrossRef

86.

Palmer RM. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot Essent Fatty Acids 1990; 39: 95–104PubMedCrossRef

87.

Trappe TA, Fluckey JD, White F, et al. Skeletal muscle PGF2a and PGE2 in response to eccentric resistance exercise: influence of ibuprofen and acetaminophen. J Clin Endocrinol Metab 2001; 86(10): 5067–70PubMedCrossRef

88.

Trappe TA, White F, Lambert CP, et al. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 2002; 282: E551–6PubMed

89.

Thorsson O, Rantanen J, Hurme T, et al. Effects of nonsteroidal antiinflammatory medication on satellite cell proliferation during muscle regeneration. Am J Sports Med 1998; 26(2): 172–6PubMed

Titel: Use of Nonsteroidal Anti-Inflammatory Drugs Following Exercise-Induced Muscle Injury
verfasst von: Angela Baldwin Lanier
Publikationsdatum: 01.03.2003
Verlag: Springer International Publishing
Erschienen in: Sports Medicine / Ausgabe 3/2003
Print ISSN: 0112-1642
Elektronische ISSN: 1179-2035
DOI: https://doi.org/10.2165/00007256-200333030-00002

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2003

Haematocrit

The Potential Value and Toxicity of Chromium Picolinate as a Nutritional Supplement, Weight Loss Agent and Muscle Development Agent

The Conscious Perception of the Sensation of Fatigue